Christopher C. Kaltenecker

918 total citations
21 papers, 643 citations indexed

About

Christopher C. Kaltenecker is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Christopher C. Kaltenecker has authored 21 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Christopher C. Kaltenecker's work include Renin-Angiotensin System Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Christopher C. Kaltenecker is often cited by papers focused on Renin-Angiotensin System Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Christopher C. Kaltenecker collaborates with scholars based in Austria, Germany and United States. Christopher C. Kaltenecker's co-authors include Marcus D. Säemann, Marlies Antlanger, Chantal Kopecky, J Kovarík, Oliver Domenig, Farsad Eskandary, Georg A. Böhmig, Nicolas Kozakowski, Philip F. Halloran and Markus Wahrmann and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Circulation Research.

In The Last Decade

Christopher C. Kaltenecker

21 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher C. Kaltenecker Austria 13 239 227 180 160 147 21 643
Alison Skene Australia 10 454 1.9× 367 1.6× 103 0.6× 59 0.4× 304 2.1× 19 925
Beatriz Tavira Spain 18 201 0.8× 163 0.7× 74 0.4× 61 0.4× 47 0.3× 39 786
Manuel Macı́a Spain 11 75 0.3× 133 0.6× 214 1.2× 101 0.6× 382 2.6× 30 757
Clara García-Carro Spain 12 53 0.2× 115 0.5× 157 0.9× 49 0.3× 148 1.0× 28 499
John R. Silkensen United States 12 302 1.3× 185 0.8× 33 0.2× 118 0.7× 137 0.9× 15 1.1k
Dominik Döller Austria 7 333 1.4× 335 1.5× 396 2.2× 38 0.2× 65 0.4× 7 607
Annalisa Teutonico Italy 15 199 0.8× 275 1.2× 90 0.5× 31 0.2× 261 1.8× 35 748
Sergio Dellepiane Italy 15 77 0.3× 186 0.8× 63 0.3× 33 0.2× 386 2.6× 27 871
Chung Hee Baek South Korea 14 118 0.5× 132 0.6× 43 0.2× 40 0.3× 187 1.3× 57 615
Jianyong Zhong United States 16 40 0.2× 82 0.4× 75 0.4× 80 0.5× 349 2.4× 41 743

Countries citing papers authored by Christopher C. Kaltenecker

Since Specialization
Citations

This map shows the geographic impact of Christopher C. Kaltenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Kaltenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Kaltenecker more than expected).

Fields of papers citing papers by Christopher C. Kaltenecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Kaltenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Kaltenecker. The network helps show where Christopher C. Kaltenecker may publish in the future.

Co-authorship network of co-authors of Christopher C. Kaltenecker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Kaltenecker. A scholar is included among the top collaborators of Christopher C. Kaltenecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Kaltenecker. Christopher C. Kaltenecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kovarík, J, Christopher C. Kaltenecker, Oliver Domenig, et al.. (2021). Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study. Diabetes Therapy. 12(9). 2485–2498. 7 indexed citations
4.
Katholnig, Karl, Christopher C. Kaltenecker, Monika Linke, et al.. (2021). p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway. PubMed. 5(12). 176–182. 4 indexed citations
5.
Kovarík, J, Anna Nele Herdina, Christopher C. Kaltenecker, et al.. (2021). Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection. Frontiers in Cellular and Infection Microbiology. 11. 651484–651484. 8 indexed citations
6.
Kaltenecker, Christopher C., Oliver Domenig, Chantal Kopecky, et al.. (2020). Critical Role of Neprilysin in Kidney Angiotensin Metabolism. Circulation Research. 127(5). 593–606. 25 indexed citations
7.
Kovarík, J, Christopher C. Kaltenecker, Chantal Kopecky, et al.. (2019). Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation. Scientific Reports. 9(1). 9762–9762. 12 indexed citations
8.
Werzowa, Johannes, Marcus D. Säemann, Michael Bergmann, et al.. (2018). A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation. PLoS ONE. 13(3). e0193569–e0193569. 10 indexed citations
9.
Eskandary, Farsad, Heinz Regele, Lukas Baumann, et al.. (2017). A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection. Journal of the American Society of Nephrology. 29(2). 591–605. 193 indexed citations
10.
Antlanger, Marlies, Oliver Domenig, J Kovarík, et al.. (2017). Molecular remodeling of the renin-angiotensin system after kidney transplantation. Journal of the Renin-Angiotensin-Aldosterone System. 18(2). 2688429072–2688429072. 6 indexed citations
11.
Antlanger, Marlies, J Kovarík, Chantal Kopecky, et al.. (2017). Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease. Annals of Medicine. 49(6). 525–533. 20 indexed citations
12.
Eskandary, Farsad, Gregor Bond, Nicolas Kozakowski, et al.. (2016). Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection—Results of a Cross-Sectional Screening Study. Transplantation. 101(3). 631–641. 55 indexed citations
13.
Domenig, Oliver, Arndt Manzel, Nadja Grobe, et al.. (2016). Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Scientific Reports. 6(1). 33678–33678. 70 indexed citations
14.
Kovarík, J, Chantal Kopecky, Marlies Antlanger, et al.. (2016). Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients. The Journal of Heart and Lung Transplantation. 36(3). 355–365. 17 indexed citations
15.
Ebtehaj, Sanam, Chantal Kopecky, Bernd Genser, et al.. (2016). Abstract 622: High-density Lipoprotein Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients. Arteriosclerosis Thrombosis and Vascular Biology. 36(suppl_1). 1 indexed citations
16.
Kopecky, Chantal, Sanam Ebtehaj, Bernd Genser, et al.. (2016). HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients. Journal of the American Society of Nephrology. 28(3). 769–775. 48 indexed citations
17.
Kopecky, Chantal, Bernd Genser, Christiane Drechsler, et al.. (2014). Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis. Clinical Journal of the American Society of Nephrology. 10(2). 224–231. 48 indexed citations
18.
Kopecky, Chantal, Michael Haidinger, Ruth Birner‐Gruenberger, et al.. (2014). Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties. Journal of the American Society of Nephrology. 26(3). 565–575. 33 indexed citations
19.
Kovarík, J, Marlies Antlanger, Oliver Domenig, et al.. (2014). Molecular regulation of the renin–angiotensin system in haemodialysis patients. Nephrology Dialysis Transplantation. 30(1). 115–123. 35 indexed citations
20.
Katholnig, Karl, Christopher C. Kaltenecker, Hiroko Hayakawa, et al.. (2013). p38α Senses Environmental Stress To Control Innate Immune Responses via Mechanistic Target of Rapamycin. The Journal of Immunology. 190(4). 1519–1527. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison Skene Breakdown of academic impact, for papers by Beatriz Tavira Breakdown of academic impact, for papers by Manuel Macı́a Breakdown of academic impact, for papers by Clara García-Carro Breakdown of academic impact, for papers by John R. Silkensen Breakdown of academic impact, for papers by Dominik Döller Breakdown of academic impact, for papers by Annalisa Teutonico Breakdown of academic impact, for papers by Sergio Dellepiane Breakdown of academic impact, for papers by Chung Hee Baek Breakdown of academic impact, for papers by Jianyong Zhong
Rankless by CCL
2026